Dendritic cell vaccine (University of Bonn)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDendritic cell vaccine (University of Bonn)

Drug Alias Namehuman telomerase reverse transcriptase (hTERT)-pulsed dendritic cells (cancer)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionTelomerase reverse transcriptase modulators

TargetsTelomerase reverse transcriptase

Therapy Area/IndicationsOvarian NeoplasmsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Bonn

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Bonn

Active IndicationsN/A

Inactive IndicationsOvarian NeoplasmsCarcinoma, Renal Cell

Other Information

ATC CodeN/A